Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 292-054-9 | CAS number: 90530-16-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- QSAR prediction: migrated from IUCLID 5.6
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
- Objective of study:
- other: adsorption, desorption, metabolism and excretion
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- QSAR
- GLP compliance:
- no
Results and discussion
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- the toxic effects of 2-propenenitrile, reaction products with 1,3-benzenedimethanamine will depend mainly on the capability to act as organic bases and also to be included in metabolic reactions leading to the formation of the reactive metabolites β-aminopropionitrile and 3,3′-iminodipropionitrile.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): bioaccumulation potential cannot be judged based on study results see it in the attachement
the toxiceffects of2-propenenitrile, reaction products with 1,3-benzenedimethanaminewill depend mainly on the capability to act as organic bases and also to be included in metabolic reactions leading to the formation of the reactive metabolitesβ-aminopropionitrile and 3,3′-iminodipropionitrile. - Executive summary:
1. The possible mechanisms of toxicity of2-propenenitrile, reaction products with 1,3-benzenedimethanaminecould be associated with the presence of some structural fragments or the formation of certain metabolites such as:
· Benzylamine andβ-aminopropanenitrile fragments included in the parent structures of MXDA and constituents A, B, C, and D.
· β-Aminopropionitrile and 3,3′-iminodipropionitrile metabolites that are able to be generated as a result of oxidative dealkylation of the constituents A, B, C, and D.
2. The toxic potency of arylaliphatic benzylamine groups could be associated with:
· The possibility to act as organic Lewis bases able to form the corresponding alkylammonium salts with the acidic residues of proteins.
· The formation of reactive metabolites, such as aldehydes, isocyanates and arene epoxides, that may form adducts with nucleophilic sites of proteins and cause different adverse effects.
In addition, the toxic effects related to the benzylamine fragments are not expected to be highly expressed, because a large portion of the metabolizing benzylamine-containing constituents is possible to be excreted as hippuric acid conjugates.
3. β-aminopropionitrile and 3,3′-iminodipropionitrile could cause toxic effects such as neurotoxicity, osteolathyrism and acute lethality. In this respect it may be noted that:
· β-aminopropionitriles (as fragments and metabolites) are considerably less toxic thanα-aminopropionitriles due to the reduced propensity to release cyanide ions. However,β-aminopropionitrile metabolites are more potent inhibitors of lysine oxidase compared to the 3,3′-iminodipropionitrile metabolite that might be formed after metabolism of constituents C and D. Inhibition of lysine oxidase by aminonitriles containing primary amine groups decreases the rate of collagen and elastin cross-link formation and produces osteolathyrism in animals.
· On the other hand, 3,3′-iminodipropionitrile is a neurotoxin with distinctive neurologic effects and pathophisiology. It induces neurobehavioral aberrations in experimental animals and massive focal accumulations of neurofilaments. These effects could be associated with the oxidative metabolism of its secondary amine group and the subsequent cyanoethenylation of the epsilon-amino groups of critical lysine residues of the neurofilament fibers.
Thus, the toxiceffects of2-propenenitrile, reaction products with 1,3-benzenedimethanaminewill depend mainly on the capability to act as organic bases and also to be included in metabolic reactions leading to the formation of the reactive metabolitesβ-aminopropionitrile and 3,3′-iminodipropionitrile.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
